Literature DB >> 23432848

Gastrointestinal well-being in subjects reporting mild gastrointestinal discomfort: characteristics and properties of a global assessment measure.

Denis Guyonnet1, Bruce Naliboff, Pascale Rondeau, Emeran Mayer, Olivier Chassany.   

Abstract

There is a lack of recognised markers for measuring gastrointestinal (GI) well-being and digestive symptoms in the general population. The aim of the present study was to demonstrate construct validity of a global assessment tool of GI well-being. In this randomised double-blind study, 197 adult women consumed either a probiotic fermented milk or a control dairy product daily during 4 weeks. GI well-being was assessed weekly using a single question and subjects indicated whether their GI well-being remained the same, improved or worsened compared with the baseline period. Responders for GI well-being were subjects reporting improvement for at least 2 weeks of the 4 weeks of intervention. Frequency of individual digestive symptoms was assessed weekly. Health-related quality of life (HRQoL) was measured at baseline and at the end of the study. Subjects reporting improvement of their GI well-being had a significantly (P<0·05) lower frequency of combined digestive symptoms than individuals with no change, whereas subjects with worsened GI well-being had a significantly (P<0·05) higher digestive symptom frequency. Number of weeks with reported GI well-being improvement was significantly (P<0·05) correlated with the decrease in digestive symptoms (r 0·58) and the HRQoL digestive comfort dimension (r 0·47). When compared with non-responders, responders had significantly (P<0·0001) fewer average digestive symptoms and higher scores on digestive comfort of the HRQoL questionnaire. The data provide construct validity for a single-item questionnaire as a measure of GI well-being improvement. These data support the use of this questionnaire as an end point for nutritional intervention in the general population.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23432848     DOI: 10.1017/S0007114513000275

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  6 in total

1.  Development and Validation of a Disease-Specific Questionnaire to Assess Patient-Reported Symptoms in Polycystic Liver Disease.

Authors:  Myrte K Neijenhuis; Tom J G Gevers; Marie C Hogan; Patrick S Kamath; Titus F M Wijnands; Ralf C P M van den Ouweland; Marie E Edwards; Jeff A Sloan; Wietske Kievit; Joost P H Drenth
Journal:  Hepatology       Date:  2016-04-15       Impact factor: 17.425

2.  The Effect of Lactobacillus plantarum 299v on Iron Status and Physical Performance in Female Iron-Deficient Athletes: A Randomized Controlled Trial.

Authors:  Ulrika Axling; Gunilla Önning; Maile A Combs; Alemtsehay Bogale; Magnus Högström; Michael Svensson
Journal:  Nutrients       Date:  2020-04-30       Impact factor: 5.717

3.  The effect of a short-term physical activity after meals on gastrointestinal symptoms in individuals with functional abdominal bloating: a randomized clinical trial.

Authors:  Mohammad Kazem Hosseini-Asl; Erfan Taherifard; Mohammad Reza Mousavi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2021

4.  Digestive Symptoms in Healthy People and Subjects With Irritable Bowel Syndrome: Validation of Symptom Frequency Questionnaire.

Authors:  Fernando Azpiroz; Denis Guyonnet; Yves Donazzolo; David Gendre; Jérôme Tanguy; Francisco Guarner
Journal:  J Clin Gastroenterol       Date:  2015-08       Impact factor: 3.062

5.  Perilla extract improves gastrointestinal discomfort in a randomized placebo controlled double blind human pilot study.

Authors:  Sybille Buchwald-Werner; Hajime Fujii; Claudia Reule; Christiane Schoen
Journal:  BMC Complement Altern Med       Date:  2014-05-27       Impact factor: 3.659

6.  The Intestinal Gas Questionnaire (IGQ): Psychometric validation of a new instrument for measuring gas-related symptoms and their impact on daily life among general population and irritable bowel syndrome.

Authors:  Martin Duracinsky; Sharon Archbold; Beatriz Lobo; Pascal Bessonneau; Frédérique Thonon; Javier Santos; Danila Guagnozzi; Nalin Payakachat; Benoit Coffin; Fernando Azpiroz; Peter J Whorwell; Olivier Chassany
Journal:  Neurogastroenterol Motil       Date:  2021-06-18       Impact factor: 3.960

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.